US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Takeda Pharmaceutical Co Ltd

14.75

-0.2900-1.93%

Post-market: 14.73-0.0200-0.14%19:50 EDT

Volume:3.70M

Turnover:54.62M

Market Cap:46.58B

PE:65.71

High:14.96

Open:14.93

Low:14.70

Close:15.04

Loading ...

Overview Company News Filings

Takeda announces oveporexton studies met all primary, secondary endpoints

Takeda Pharmaceutical's Potential Narcolepsy Treatment Meets Endpoints in 2 Studies

MT Newswires Live

20 Chinese Nationals in Sragen Deported for Violating Immigration Laws

Takeda Pharmaceutical Receives FDA Approval for Ready-to-Use Liquid Immunoglobulin Therapy

MT Newswires Live

Yomiuri: Japanese Pharmaceutical Industry Struggles Against Global Trend Toward Biopharmaceuticals

Takeda Pharmaceutical Receives European Commission Approval for Adcetris Regimen to Treat Hodgkin Lymphoma

MT Newswires Live

Protagonist, Takeda announces Phase 3 VERIFY study met primary endpoint

Protagonist and Takeda Announce ASCO Plenary Presentation Highlighting Full 32-Week Results from Phase 3 VERIFY Study of Rusfertide, Showing Reductions in Phlebotomy, Improved Hematocrit Control in Polycythemia Vera

Nyse Order Imbalance 101188.0 Shares on Sell Side

THOMSON REUTERS

Xoma Royalty Acquires Mezagitamab Royalty, Milestone Rights From BioInvent

MT Newswires Live

Press Release: Keros Therapeutics Highlights Commitment to Maximizing Stockholder Value

Takeda publishes oveporexton data in New England Journal of Medicine

Asian Equities Traded in the US as American Depositary Receipts Surge in Monday Trading

MT Newswires Live

Stock Track | Takeda Pharmaceutical Plummets 5.01% After Reporting Lower Q4 Earnings

Japanese Pharma Company Takeda Expects Limited Exposure To US-China Tariffs

Sector Update: Health Care Stocks Decline Pre-Bell Thursday

MT Newswires Live

Takeda Pharmaceutical Fiscal Q4 Core Earnings Fall, Revenue Rises

MT Newswires Live

Takeda Issues FY2025 Guidance With Core Revenue Of ¥4,530B And Core Operating Profit Broadly Flat At ¥1,140B; Proposes Dividend Increase From ¥196 To ¥200 Per Share

Takeda Pharmaceutical Q4 Adj. EPADS $0.16 Down From $0.24 YoY, Sales $7.02B Down From $7.08B YoY

Press Release: Takeda Announces FY2024 Full Year Results and FY2025 Outlook Reflecting Growth & Launch Products Momentum, Strong Cash Flow Generation and Late-Stage Pipeline Progress

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/TAK/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TAK","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TAK\",,,,,undefined,":{"symbol":"TAK","market":"US","secType":"STK","nameCN":"Takeda Pharmaceutical Co Ltd","latestPrice":14.75,"timestamp":1752609600000,"preClose":15.04,"halted":0,"volume":3700294,"hourTrading":{"tag":"盘后","latestPrice":14.73,"preClose":14.75,"latestTime":"19:50 EDT","volume":6325,"amount":93278.73,"timestamp":1752623431357},"delay":0,"floatShares":3156280755,"shares":3158218006,"eps":0.224477,"marketStatus":"Closed","change":-0.29,"latestTime":"07-15 16:00:00 EDT","open":14.93,"high":14.96,"low":14.7,"amount":54618211.788764,"amplitude":0.017287,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.224477,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1752652800000},"marketStatusCode":5,"adr":0,"adrRate":0.5,"listingDate":1545627600000,"exchange":"NYSE","adjPreClose":15.04,"dividendRate":0.045964,"preHourTrading":{"tag":"盘前","latestPrice":14.92,"preClose":15.04,"latestTime":"09:29 EDT","volume":390,"amount":5918.63376,"timestamp":1752586197076},"postHourTrading":{"tag":"盘后","latestPrice":14.73,"preClose":14.75,"latestTime":"19:50 EDT","volume":6325,"amount":93278.73,"timestamp":1752623431357},"volumeRatio":1.26645,"impliedVol":0.391,"impliedVolPercentile":0.744},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TAK\",,,,,undefined,":{"symbol":"TAK","floatShares":3156280755,"roa":"2.40%","roe":"1.52%","lyrEps":0.228242,"volumeRatio":1.26645,"shares":3158218006,"dividePrice":0.658756,"high":14.96,"amplitude":0.017287,"preClose":15.04,"low":14.7,"week52Low":12.8,"pbRate":"1.00","psRate":"1.51","week52High":15.53,"institutionHeld":0.09,"latestPrice":14.75,"eps":0.224477,"divideRate":0.044661,"volume":3700294,"delay":0,"ttmEps":0.224477,"open":14.93,"prevYearClose":13.24,"prevWeekClose":14.68,"prevMonthClose":15.46,"prevQuarterClose":15.46,"fiveDayClose":15.02,"twentyDayClose":15.2,"sixtyDayClose":14.65,"earningDate":1753804800000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TAK\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2551012759","title":"Takeda announces oveporexton studies met all primary, secondary endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2551012759","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551012759?lang=en_us&edition=fundamental","pubTime":"2025-07-14 17:25","pubTimestamp":1752485145,"startTime":"0","endTime":"0","summary":"Takeda (TAK) announced that all primary and secondary endpoints were met in two Phase 3 randomized, double-blind, placebo-controlled studies of ove...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-announces-oveporexton-studies-met-all-primary-secondary-endpoints-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-announces-oveporexton-studies-met-all-primary-secondary-endpoints-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TAK"],"gpt_icon":0},{"id":"2551903677","title":"Takeda Pharmaceutical's Potential Narcolepsy Treatment Meets Endpoints in 2 Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2551903677","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551903677?lang=en_us&edition=fundamental","pubTime":"2025-07-14 16:02","pubTimestamp":1752480125,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical  said Monday that two phase 3 studies of its investigational therapy oveporexton for the treatment of narcolepsy type 1 met all primary and secondary endpoints.The two studies showed \"statistically significant\" and \"clinically meaningful\"  improvement in wakefulness, daytime sleeping, cataplexy, ability to maintain attention, overall quality of life, and daily life functions, with patients \"achieving near normal ranges across the broad range of symptoms investigated,\" the company said.Takeda said it intends to submit a new drug application with the US Food and Drug Administration and other worldwide regulatory authorities in fiscal 2025.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TAK"],"gpt_icon":0},{"id":"2551735329","title":"20 Chinese Nationals in Sragen Deported for Violating Immigration Laws","url":"https://stock-news.laohu8.com/highlight/detail?id=2551735329","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551735329?lang=en_us&edition=fundamental","pubTime":"2025-07-14 11:15","pubTimestamp":1752462945,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Karanganyar - The Surakarta Class I TPI Immigration Office carried out Administrative Immigration Measures  by deporting 20 foreign nationals or Chinese nationals on Monday, July 14, 2025. The 20 Chinese nationals violated Article 122 of Law Number 6 of 2011 concerning Immigration.The head of the Surakarta Immigration Office, Bisri, stated that this TAK originated from community information regarding the presence of several foreign nationals who were working on a company project in Plumbon Village, Sambungmacan District, Sragen Regency, Central Java.This information was immediately followed up by the Surakarta Immigration Office. There were a total of 21 foreign nationals arrested while working on the project.","market":"other","thumbnail":"https://statik.tempo.co/data/2025/07/14/id_1412831/1412831_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2025/07/14/id_1412831/1412831_720.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2027965/20-chinese-nationals-in-sragen-deported-for-violating-immigration-laws","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["TAK","BK4007"],"gpt_icon":0},{"id":"2547557094","title":"Takeda Pharmaceutical Receives FDA Approval for Ready-to-Use Liquid Immunoglobulin Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2547557094","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547557094?lang=en_us&edition=fundamental","pubTime":"2025-06-30 20:55","pubTimestamp":1751288119,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical  said Monday it received US Food and Drug Administration approval for Gammagard Liquid erc, a ready-to-use liquid immunoglobulin therapy for the treatment of primary immunodeficiency in patients aged two and older.Takeda said US commercialization is expected in 2026, followed by a European Union launch by 2027, where the therapy is approved.The company said it will discontinue manufacturing of its older freeze-dried formulation Gammagard s/d by the end of 2027 due to supply limitations.Shares of Takeda were up past 1% in recent premarket activity.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","TAK"],"gpt_icon":0},{"id":"2544955705","title":"Yomiuri: Japanese Pharmaceutical Industry Struggles Against Global Trend Toward Biopharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2544955705","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544955705?lang=en_us&edition=fundamental","pubTime":"2025-06-17 15:51","pubTimestamp":1750146660,"startTime":"0","endTime":"0","summary":"Pharmaceuticals have seen a worldwide shift from small-molecule drugs to biopharmaceuticals in recent years. The trend has jolted the Japanese drug industry, which excels in medications with a low molecular weight.This article explores the future of the Japanese pharmaceutical industry by examining three companies: Shionogi & Co., Takeda Pharmaceutical Co. and Mitsubishi Tanabe Pharma Corp. The companies were once dubbed the \"Big Three\" of Doshomachi, a district in Chuo Ward, Osaka, known as the birthplace of many drug companies since the Edo period .Shionogi has licensed the development and sales rights of Crestor to AstraZeneca PLC. Supported by huge patent revenue coming in from the British pharmaceutical company, Shionogi has put its efforts into developing drugs to fight infectious diseases, and those efforts have paid off, with promising medications developed for the flu and COVID-19. The Japanese company has also secured royalties for HIV drugs through the mid-2030s, ensuring so","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WEBR","TAK","BK4191","BK4007","BK4539"],"gpt_icon":0},{"id":"2540708952","title":"Takeda Pharmaceutical Receives European Commission Approval for Adcetris Regimen to Treat Hodgkin Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2540708952","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540708952?lang=en_us&edition=fundamental","pubTime":"2025-06-03 23:04","pubTimestamp":1748963054,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical  said Tuesday the European Commission approved Adcetris in combination with a chemotherapy regimen to treat patients with stage 2b, 3 and 4 Hodgkin lymphoma.The Commission's approval follows a recommendation from the Committee for Medicinal Products for Human Use on April 25, according to a statement.The approval is based on the phase 3 HD21 trial, which achieved its co-primary safety and efficacy endpoints, the company said.It added that the development marks the second approval for the drug regimen for the treatment of Hodgkin lymphoma.Price: 14.99, Change: -0.09, Percent Change: -0.60","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TAK","BK4007"],"gpt_icon":0},{"id":"2540573095","title":"Protagonist, Takeda announces Phase 3 VERIFY study met primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2540573095","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540573095?lang=en_us&edition=fundamental","pubTime":"2025-06-02 04:05","pubTimestamp":1748808311,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics (PTGX) and Takeda (TAK) announced detailed results from the Phase 3, randomized, placebo-controlled VERIFY study evaluatin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/protagonist-takeda-announces-phase-3-verify-study-met-primary-endpoint-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/protagonist-takeda-announces-phase-3-verify-study-met-primary-endpoint-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PTGX","BK4007","TAK"],"gpt_icon":0},{"id":"2540371177","title":"Protagonist and Takeda Announce ASCO Plenary Presentation Highlighting Full 32-Week Results from Phase 3 VERIFY Study of Rusfertide, Showing Reductions in Phlebotomy, Improved Hematocrit Control in Polycythemia Vera","url":"https://stock-news.laohu8.com/highlight/detail?id=2540371177","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540371177?lang=en_us&edition=fundamental","pubTime":"2025-06-01 20:00","pubTimestamp":1748779200,"startTime":"0","endTime":"0","summary":"Rusfertide plus current standard of care more than doubled clinical response rates across high- and low-risk PV groups, significantly reducing phlebotomy eligibility compared to placebo plus current standard of care, which was the primary endpoint. All key secondary endpoints met with statistical significance, including a nearly three-fold reduction in the proportion of patients requiring phlebotomy and a four-fold improvement in hematocrit control in rusfertide arm compared to placebo arm, as well as improvements in patient-reported outcomes. No serious adverse events considered related to rusfertide were reported. Rusfertide has received Orphan Drug designation and Fast Track designation from the U.S. FDA. \"PV poses significant challenges for patients, including debilitating symptoms and the risk of serious thrombotic events, and hematocrit control is crucial to improving patient outcomes. The VERIFY study demonstrated that treatment with rusfertide controls hematocrit levels in phle","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/protagonist-takeda-announce-asco-plenary-120000807.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BLSP4452.SGD","LU1244550494.USD","IE00BFTCPJ56.SGD","IE00B3PB1722.GBP","LU1057294990.SGD","LU1244550221.USD","LU1066051225.USD","LU1914381329.SGD","BK4533","LU0234572021.USD","LU2430703251.USD","LU2505996681.GBP","PTGX","BK4588","IE00BJJMRZ35.SGD","LU0985320562.USD","LU1059921491.USD","LU1066051811.HKD","LU0345769631.USD","LU1430594728.SGD","LU0466842654.USD","LU1585245621.USD","LU0203345920.USD","LU1674673691.USD","LU1066051498.USD","LU1778281490.HKD","LU0122379950.USD","LU1718418525.SGD","LU1244550577.SGD","LU1506573853.SGD","BK4504","IE00B7SZLL34.SGD","IE00BLSP4239.USD","IE00BVYPNW00.USD","BK4581","LU0203347892.USD","TAK","IE00B2B36J28.USD","LU1732800096.USD","IE00BFXG1179.USD","BK4585","IE00B42XCP33.USD","LU1280957306.USD","LU1066053197.SGD","LU0795875169.SGD","BK4532","BK4592","LU1023059063.AUD","IE00B19Z3B42.SGD","JNJ"],"gpt_icon":0},{"id":"2539293619","title":"Nyse Order Imbalance  101188.0 Shares on Sell Side","url":"https://stock-news.laohu8.com/highlight/detail?id=2539293619","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539293619?lang=en_us&edition=fundamental","pubTime":"2025-05-30 03:50","pubTimestamp":1748548202,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250529:nAQN2KGN29:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TAK","BK4007"],"gpt_icon":0},{"id":"2538460115","title":"Xoma Royalty Acquires Mezagitamab Royalty, Milestone Rights From BioInvent","url":"https://stock-news.laohu8.com/highlight/detail?id=2538460115","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538460115?lang=en_us&edition=fundamental","pubTime":"2025-05-27 22:58","pubTimestamp":1748357917,"startTime":"0","endTime":"0","summary":"Xoma Royalty (XOMA) said Tuesday that it acquired the future royalty and milestone interests in mezagitamab held by BioInvent for a total of up to $30 million.Mezagitamab, being developed by Takeda Ph","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","TAK","BK4139","XOMA"],"gpt_icon":0},{"id":"2536689191","title":"Press Release: Keros Therapeutics Highlights Commitment to Maximizing Stockholder Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2536689191","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536689191?lang=en_us&edition=fundamental","pubTime":"2025-05-19 20:01","pubTimestamp":1747656060,"startTime":"0","endTime":"0","summary":"Files Investor Presentation and Issues Open Letter to Stockholders. Urges Stockholders to Protect the Value of Their Investment by Voting \"FOR\" Each of the Company's Highly Qualified Director Nominees. LEXINGTON, Mass., May 19, 2025  -- Keros Therapeutics, Inc.  , a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta  family of proteins, today filed an investor presentation with the U.S. Securities and Exchange Commission  and issued an open letter to stockholders in connection with its upcoming Annual Meeting of Stockholders  scheduled to be held on June 4, 2025. Stockholders of record as of April 7, 2025, will be entitled to vote at the Annual Meeting.The full text of the letter being mailed to stockholders is as follows:. We strongly recommend that you vote \"FOR\" each of Keros' three highly qualified and ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","KROS","TAK","BK4539","BK4007","BK4139"],"gpt_icon":0},{"id":"2535883247","title":"Takeda publishes oveporexton data in New England Journal of Medicine","url":"https://stock-news.laohu8.com/highlight/detail?id=2535883247","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535883247?lang=en_us&edition=fundamental","pubTime":"2025-05-15 05:10","pubTimestamp":1747257017,"startTime":"0","endTime":"0","summary":"Takeda (TAK) announced that the New England Journal of Medicine published data from the Phase 2b trial of oveporexton in people with narcolepsy typ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-publishes-oveporexton-data-in-new-england-journal-of-medicine?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-publishes-oveporexton-data-in-new-england-journal-of-medicine?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK","BK4007"],"gpt_icon":0},{"id":"2534272076","title":"Asian Equities Traded in the US as American Depositary Receipts Surge in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2534272076","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534272076?lang=en_us&edition=fundamental","pubTime":"2025-05-12 22:37","pubTimestamp":1747060626,"startTime":"0","endTime":"0","summary":"Asian equities traded in the US as American depositary receipts surged Monday morning, climbing 3.4% to 2,226.7 on the S&P Asia 50 ADR Index, as investors welcomed US and China trade talks.From North Asia, the gainers were led by internet and data center services provider VNET Group  and computer hardware maker Canaan , which jumped past 20% and 14% respectively. They were followed by diagnostic imaging centers company Concord Medical Services  and fintech firm LexinFintech , which rose over 12% and 11% respectively.The decliners from North Asia were led by Highest Performances , which fell 8.8%, followed by pharmaceutical company Takeda Pharmaceutical  and utilities provider Korea Electric Power , which dropped 2.3% and 1.1% respectively.From South Asia, the gainers were led by IT firms Infosys  and Sify Technologies , which climbed 5.8% and 5% respectively. They were followed by IT company Wipro  and financial services company ICICI Bank , which were up 4.8% and 3.6% respectively.The","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1508157978.USD","BK4207","IE00BYTNYM70.SGD","LU1868837722.USD","AFG","SIFY","BK4170","BK4595","SG9999004220.SGD","LU0164881194.USD","LU0048575426.USD","BK4579","LU0791590937.USD","LU0828237940.HKD","LU0862451753.SGD","LU0231203729.USD","LX","IE00B0JY6M65.USD","LU0333810181.USD","LU0348744763.USD","CAN","VNET","CAN.AU","BK4116","LU1366334651.USD","LU0708995666.HKD","IBN","LU0823038988.USD","BK4523","LU1102505762.USD","WIT","INFY","LU2265009873.SGD","LU0261950470.USD","LU2087589342.USD","LU1805238398.USD","MAAS","LU1804176565.USD","BK4526","TAK","LU1267930656.SGD","BK4089","BK4081","LU1323998911.USD","LU0823039010.USD","LU0890818403.SGD","KEP","IE00B7N09G41.SGD","CCM.AU","CCM"],"gpt_icon":1},{"id":"1109491881","title":"Stock Track | Takeda Pharmaceutical Plummets 5.01% After Reporting Lower Q4 Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=1109491881","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109491881?lang=en_us&edition=fundamental","pubTime":"2025-05-08 22:35","pubTimestamp":1746714957,"startTime":"0","endTime":"0","summary":"Shares of Takeda Pharmaceutical Co Ltd  plummeted 5.01% in pre-market trading on Thursday following the release of its fiscal fourth-quarter earnings report, which showed a significant decline in core earnings.The Japanese pharmaceutical giant reported quarterly earnings of $0.16 per share, marking a substantial 33.33% decrease from $0.24 per share in the same period last year. Sales also saw a slight dip, coming in at $7.02 billion for the quarter, down 0.93% from $7.08 billion in the previous ","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Stock Track | Takeda Pharmaceutical Plummets 5.01% After Reporting Lower Q4 Earnings","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["TAK"],"gpt_icon":0},{"id":"2533134107","title":"Japanese Pharma Company Takeda Expects Limited Exposure To US-China Tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2533134107","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533134107?lang=en_us&edition=fundamental","pubTime":"2025-05-08 22:32","pubTimestamp":1746714723,"startTime":"0","endTime":"0","summary":"Takeda reported a 25% drop in FY2024 net profit but saw revenue and operating profit growth.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/general/biotech/25/05/45289103/japanese-pharma-company-takeda-expects-limited-exposure-to-us-china-tariffs","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0912757837.SGD","LU0456854461.SGD","LU0122376428.USD","IE00B3CCJ963.GBP","SG9999014567.USD","LU0368265418.SGD","LU0278409577.USD","BK4570","LU2498475776.HKD","LU1066051498.USD","LU2592432038.USD","SG9999014542.SGD","LU1732800096.USD","IE00BWXC8680.SGD","IE00B2Q91V27.USD","BK4007","LU2505996681.GBP","IE00B1XK9C88.USD","LU1150488135.SGD","LU0466842654.USD","LU0630314457.HKD","SG9999014559.SGD","LU1150488218.USD","LU1489326972.SGD","IE000M9KFDE8.USD","LU2462611646.USD","LU1430597077.USD","PDT","LU0149725797.USD","LU0612318971.USD","LU0889566641.SGD","LU0795875086.SGD","TAK","BK4588","XOM","LU0433182093.SGD","LU2133065610.SGD","SG9999002232.USD","LU0203347892.USD","LU0345781412.USD","LU0878866978.SGD","LU0300736062.USD","LU1839511570.USD","LU2430703251.USD","LU2505996509.AUD","BK4592","LU0170899867.USD","LU0795875169.SGD","BK4534"],"gpt_icon":0},{"id":"2533013330","title":"Sector Update: Health Care Stocks Decline Pre-Bell Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=2533013330","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533013330?lang=en_us&edition=fundamental","pubTime":"2025-05-08 21:18","pubTimestamp":1746710296,"startTime":"0","endTime":"0","summary":"Health care stocks were declining pre-bell Thursday, with The Health Care Select Sector SPDR Fund (XLV) down 0.9% and the iShares Biotechnology ETF (IBB) 0.7% lower.Takeda Pharmaceutical (TAK) shares ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["STVN","IBB","XLV","LU0889565916.HKD","TAK","BK4588","BK4007","BK4505","BK4121","ARGX","BK4539","BK4585","BK4139","LU0320765992.SGD","LU0109394709.USD","BK4581"],"gpt_icon":0},{"id":"2533976556","title":"Takeda Pharmaceutical Fiscal Q4 Core Earnings Fall, Revenue Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2533976556","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533976556?lang=en_us&edition=fundamental","pubTime":"2025-05-08 16:52","pubTimestamp":1746694345,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical  reported fiscal Q4 core earnings Thursday of 49 Japanese yen  per share, down from 72 yen a year earlier.Four analysts polled by FactSet expected 55.38 yen.Revenue for the quarter ended March 31 was 1.053 trillion yen, up from 1.051 trillion yen a year earlier.Analysts surveyed by FactSet expected 1.073 trillion yen.The company expects core EPS for its next fiscal year to be 485 yen. Analysts surveyed by FactSet expect 508.33 yen.The company expects full-year revenue of 4.530 trillion yen. Analysts polled by FactSet expects 4.602 trillion yen.Takeda shares were down 3% in recent premarket activity.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TAK"],"gpt_icon":0},{"id":"2533924289","title":"Takeda Issues FY2025 Guidance With Core Revenue Of ¥4,530B And Core Operating Profit Broadly Flat At ¥1,140B; Proposes Dividend Increase From ¥196 To ¥200 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2533924289","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533924289?lang=en_us&edition=fundamental","pubTime":"2025-05-08 15:20","pubTimestamp":1746688826,"startTime":"0","endTime":"0","summary":"FY2025 Outlook(Billion yen, except percentages and per share amounts)ItemFY2025 FORECASTFY2025MANAGEMENTGUIDANCECore Change at CER(Non-IFRS)Revenue4,530.0---Core Revenue (Non-IFRS)4,530.0Broadly flatOperating","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45277336/takeda-issues-fy2025-guidance-with-core-revenue-of-4-530b-and-core-operating-profit-broadly-flat-at","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TAK"],"gpt_icon":0},{"id":"2533392146","title":"Takeda Pharmaceutical Q4 Adj. EPADS $0.16 Down From $0.24 YoY, Sales $7.02B Down From $7.08B YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2533392146","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533392146?lang=en_us&edition=fundamental","pubTime":"2025-05-08 15:07","pubTimestamp":1746688021,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical (NYSE:TAK) reported quarterly earnings of $0.16 per share. This is a 33.33 percent decrease over earnings of $0.24 per share from the same period last year.  The company reported $7.02 billion in","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45277250/takeda-pharmaceutical-q4-adj-epads-0-16-down-from-0-24-yoy-sales-7-02b-down-from-7-08b-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TAK"],"gpt_icon":0},{"id":"2533926913","title":"Press Release: Takeda Announces FY2024 Full Year Results and FY2025 Outlook Reflecting Growth & Launch Products Momentum, Strong Cash Flow Generation and Late-Stage Pipeline Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2533926913","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533926913?lang=en_us&edition=fundamental","pubTime":"2025-05-08 14:36","pubTimestamp":1746686160,"startTime":"0","endTime":"0","summary":"Takeda Announces FY2024 Full Year Results and FY2025 Outlook Reflecting Growth & Launch Products Momentum, Strong Cash Flow Generation and Late-Stage Pipeline Progress. -- Core Revenue Growth of 7.4% at Actual Exchange Rates , + 2.8% at. -- Core Operating Profit Growth of 4.9% at CER with Efficiency Program. -- Up to Six New Molecular Entities in Phase 3 Development in FY2025 with. Three Phase 3 Data Readouts Recently Completed or Anticipated. -- FY2025 Outlook for Broadly Flat Revenue and Core Profit Reflecting. Product Momentum and Increasing Investment in New Launch Preparation. \"FY2025 will be a pivotal year as we invest in launch readiness for the late-stage pipeline, which will contribute to our broadly flat Core Operating Profit outlook for FY2025 but will be key to achieving Takeda's long-term growth potential.\". FINANCIAL HIGHLIGHTS for FY2024 Ended March 31, 2025","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TAK","BK4022","LU2065732104.USD","LU0109981661.USD","PRGS","BK4572","LU0211331839.USD","LU1098665638.USD","AER","BK4104","R","BK4097","BK4232","SSI"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":74,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TAK\",params:#limit:5,,,undefined,":[{"date":"2025-07-30","symbol":"TAK","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":"2025/06","expectedEps":0.47,"defaultRemindTime":1753862400000,"name":null,"time":"","dateTimestamp":1753848000000,"actualEps":null},{"market":"US","date":"2025-01-30","symbol":"TAK","fiscalQuarterEnding":"2024/12","expectedEps":0.34,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738213200000,"reportTimeType":"pre","actualEps":0.42},{"market":"US","date":"2024-10-31","symbol":"TAK","fiscalQuarterEnding":"2024/09","expectedEps":0.39,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730347200000,"reportTimeType":"pre","actualEps":0.44},{"market":"US","date":"2024-07-31","symbol":"TAK","fiscalQuarterEnding":"2024/06","expectedEps":0.37,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722398400000,"reportTimeType":"pre","actualEps":0.56},{"market":"US","date":"2024-05-09","symbol":"TAK","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"pre","actualEps":0}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TAK\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TAK\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.5,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":4,"updateTime":1689480000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TAK\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TAK","date":"2025-07-14","current":63.806374,"percent":0.932,"low":9.919003,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"high":134.825067,"avg":34.403156,"sd":22.932994,"marketCap":46678287018.21},"quantilePoints":[{"date":"2020-07-17","current":130.667664,"twenty":28.683495,"median":36.800541,"eighty":86.385434,"marketCap":53972328180.49},{"date":"2020-07-24","current":133.164486,"twenty":28.804715,"median":36.81694,"eighty":87.725687,"marketCap":55658397179.21},{"date":"2020-07-31","current":49.030087,"twenty":28.880318,"median":36.830882,"eighty":88.33002,"marketCap":55557224542.23},{"date":"2020-08-07","current":49.695831,"twenty":29.000288,"median":36.883572,"eighty":88.247168,"marketCap":56220621340.2},{"date":"2020-08-14","current":51.954139,"twenty":29.120238,"median":36.973174,"eighty":88.149695,"marketCap":58424376584.77},{"date":"2020-08-21","current":52.698206,"twenty":29.210125,"median":37.019329,"eighty":87.725687,"marketCap":59589605364.98},{"date":"2020-08-28","current":51.875816,"twenty":29.296114,"median":37.194931,"eighty":87.39428,"marketCap":59006258563.45},{"date":"2020-09-04","current":50.217983,"twenty":29.358735,"median":37.349685,"eighty":86.853304,"marketCap":56544754820.4},{"date":"2020-09-11","current":51.079534,"twenty":29.413482,"median":37.496711,"eighty":86.502401,"marketCap":57600970548.14},{"date":"2020-09-18","current":52.071623,"twenty":29.482546,"median":37.644832,"eighty":86.409802,"marketCap":59718536367.45},{"date":"2020-09-25","current":51.23618,"twenty":29.528429,"median":37.70687,"eighty":86.307455,"marketCap":58079537631.11},{"date":"2020-10-02","current":47.267823,"twenty":29.55872,"median":37.818162,"eighty":86.127131,"marketCap":53733241411.92},{"date":"2020-10-09","current":48.45572,"twenty":29.570204,"median":38.056274,"eighty":85.695464,"marketCap":54928745380.19},{"date":"2020-10-16","current":45.740528,"twenty":29.581756,"median":38.101028,"eighty":85.328548,"marketCap":51955606617.4},{"date":"2020-10-23","current":45.688313,"twenty":29.610527,"median":38.151519,"eighty":85.068348,"marketCap":52213782354.12},{"date":"2020-10-30","current":90.341121,"twenty":29.668895,"median":38.172466,"eighty":85.328548,"marketCap":48419952386.27},{"date":"2020-11-06","current":96.588856,"twenty":29.692357,"median":38.217233,"eighty":86.409802,"marketCap":52398853598.67},{"date":"2020-11-13","current":100.410015,"twenty":29.692593,"median":38.315348,"eighty":87.847529,"marketCap":53780559103.29},{"date":"2020-11-20","current":101.776706,"twenty":29.697927,"median":38.413443,"eighty":88.520092,"marketCap":54951029488.93},{"date":"2020-11-27","current":104.091715,"twenty":29.726253,"median":38.431569,"eighty":89.212151,"marketCap":56090722051.49},{"date":"2020-12-04","current":108.749624,"twenty":29.809673,"median":41.476727,"eighty":89.840851,"marketCap":58500568009.94},{"date":"2020-12-11","current":107.940766,"twenty":29.825396,"median":42.195512,"eighty":90.113776,"marketCap":58227511975.44},{"date":"2020-12-18","current":108.136007,"twenty":29.898634,"median":42.406568,"eighty":90.568631,"marketCap":58641544051.05},{"date":"2020-12-24","current":104.063823,"twenty":29.940017,"median":42.671516,"eighty":90.966664,"marketCap":56275869966.77},{"date":"2020-12-31","current":104.733224,"twenty":29.971299,"median":42.851076,"eighty":91.332188,"marketCap":56879881356.69},{"date":"2021-01-08","current":103.059723,"twenty":29.97912,"median":42.920583,"eighty":91.791488,"marketCap":55589135003.46},{"date":"2021-01-15","current":100.437906,"twenty":29.989622,"median":43.181235,"eighty":92.111972,"marketCap":54236546808.57},{"date":"2021-01-22","current":100.047423,"twenty":30.031602,"median":43.418717,"eighty":92.258181,"marketCap":54029329143.49},{"date":"2021-01-29","current":103.143398,"twenty":30.073173,"median":43.598578,"eighty":92.394644,"marketCap":55216620705.7},{"date":"2021-02-05","current":31.781037,"twenty":30.157692,"median":43.665039,"eighty":92.535979,"marketCap":54432227223.55},{"date":"2021-02-12","current":31.919516,"twenty":30.223066,"median":43.441886,"eighty":92.526232,"marketCap":54935581599.54},{"date":"2021-02-19","current":31.997411,"twenty":30.238705,"median":43.337626,"eighty":92.438506,"marketCap":54757645997.71},{"date":"2021-02-26","current":31.00209,"twenty":30.269781,"median":42.961129,"eighty":92.297171,"marketCap":52506642547.95},{"date":"2021-03-05","current":32.525364,"twenty":30.307584,"median":42.874245,"eighty":92.272802,"marketCap":54273339139.55},{"date":"2021-03-12","current":34.741035,"twenty":30.314105,"median":42.671516,"eighty":92.258181,"marketCap":57572160306.5},{"date":"2021-03-19","current":36.991326,"twenty":30.320622,"median":42.376112,"eighty":92.258181,"marketCap":61377881020.81},{"date":"2021-03-26","current":36.385479,"twenty":30.34278,"median":42.069006,"eighty":92.219192,"marketCap":59972674222.12},{"date":"2021-04-01","current":35.38287,"twenty":30.371454,"median":41.476727,"eighty":92.150961,"marketCap":57783874962.89},{"date":"2021-04-09","current":32.481215,"twenty":30.393667,"median":38.431569,"eighty":92.111972,"marketCap":53478879478.89},{"date":"2021-04-16","current":32.082779,"twenty":30.470959,"median":38.377853,"eighty":92.111972,"marketCap":53250001858.4},{"date":"2021-04-23","current":31.900884,"twenty":30.513064,"median":38.294386,"eighty":92.058362,"marketCap":53341682665.94},{"date":"2021-04-30","current":31.485125,"twenty":30.533079,"median":38.21414,"eighty":91.833434,"marketCap":52029509066.16},{"date":"2021-05-07","current":31.831591,"twenty":30.534382,"median":38.169603,"eighty":91.791488,"marketCap":52970833572.63},{"date":"2021-05-14","current":15.564762,"twenty":30.470959,"median":38.145677,"eighty":91.758112,"marketCap":53496176267.97},{"date":"2021-05-21","current":15.876889,"twenty":30.319318,"median":38.091991,"eighty":91.609986,"marketCap":54795356598.76},{"date":"2021-05-28","current":15.664642,"twenty":30.236167,"median":38.041392,"eighty":91.546628,"marketCap":53587690959.61},{"date":"2021-06-04","current":15.281766,"twenty":30.057838,"median":37.818162,"eighty":91.527134,"marketCap":52499044333.6},{"date":"2021-06-11","current":15.732274,"twenty":29.940017,"median":37.70687,"eighty":91.283451,"marketCap":53886220157.49},{"date":"2021-06-18","current":15.499142,"twenty":29.705398,"median":37.644832,"eighty":91.259083,"marketCap":52855138856.99},{"date":"2021-06-25","current":15.64495,"twenty":29.653254,"median":37.496711,"eighty":91.185978,"marketCap":53110087882.29},{"date":"2021-07-02","current":15.624135,"twenty":29.556114,"median":37.309512,"eighty":90.966664,"marketCap":52790633079.89},{"date":"2021-07-09","current":15.170356,"twenty":29.369182,"median":37.239049,"eighty":90.713234,"marketCap":51765371608.86},{"date":"2021-07-16","current":15.553362,"twenty":29.036801,"median":37.034171,"eighty":90.649877,"marketCap":53089153550.44},{"date":"2021-07-23","current":15.445121,"twenty":28.610503,"median":36.990446,"eighty":90.630383,"marketCap":52540828243.5},{"date":"2021-07-30","current":13.400212,"twenty":26.987384,"median":36.968687,"eighty":90.397999,"marketCap":52641482781.37},{"date":"2021-08-06","current":13.231512,"twenty":25.788836,"median":36.881192,"eighty":90.295707,"marketCap":51739766156.6},{"date":"2021-08-13","current":13.399277,"twenty":25.542527,"median":36.851251,"eighty":90.284353,"marketCap":52624385513.69},{"date":"2021-08-20","current":13.340924,"twenty":25.375364,"median":36.822486,"eighty":90.167386,"marketCap":52391869685.63},{"date":"2021-08-27","current":13.304453,"twenty":25.07978,"median":36.81694,"eighty":90.040671,"marketCap":52184954198.97},{"date":"2021-09-03","current":13.585277,"twenty":24.895379,"median":36.800541,"eighty":89.938325,"marketCap":53414238064.1},{"date":"2021-09-10","current":13.6801,"twenty":24.732641,"median":36.787118,"eighty":89.91883,"marketCap":53684261064.92},{"date":"2021-09-17","current":13.906217,"twenty":24.583535,"median":36.72461,"eighty":89.874967,"marketCap":54565644835.19},{"date":"2021-09-24","current":13.753041,"twenty":24.444102,"median":36.66065,"eighty":89.831104,"marketCap":53563443001.25},{"date":"2021-10-01","current":13.260689,"twenty":24.187434,"median":36.617455,"eighty":89.777494,"marketCap":51482210756.95},{"date":"2021-10-08","current":11.666926,"twenty":23.93319,"median":36.601121,"eighty":89.748252,"marketCap":44862900501.13},{"date":"2021-10-15","current":11.787279,"twenty":23.7033,"median":36.578836,"eighty":89.499696,"marketCap":44516597060.99},{"date":"2021-10-22","current":11.681514,"twenty":23.539863,"median":36.5454,"eighty":88.968468,"marketCap":44293684279.19},{"date":"2021-10-29","current":10.648321,"twenty":23.423498,"median":36.488155,"eighty":88.710165,"marketCap":44164269191.12},{"date":"2021-11-05","current":10.784625,"twenty":23.226892,"median":36.468627,"eighty":88.627312,"marketCap":44983557825.66},{"date":"2021-11-12","current":10.950849,"twenty":22.951173,"median":36.398869,"eighty":88.490851,"marketCap":45493195113.2},{"date":"2021-11-19","current":10.728109,"twenty":22.593579,"median":36.365388,"eighty":88.33002,"marketCap":44596449686.83},{"date":"2021-11-26","current":10.425581,"twenty":22.055183,"median":36.25968,"eighty":88.252042,"marketCap":43512424769.26},{"date":"2021-12-03","current":10.106651,"twenty":21.515452,"median":36.172679,"eighty":88.178937,"marketCap":42286529642.36},{"date":"2021-12-10","current":10.142864,"twenty":21.321368,"median":36.088488,"eighty":87.847529,"marketCap":42348534488.31},{"date":"2021-12-17","current":10.34424,"twenty":21.015505,"median":36.02197,"eighty":87.423521,"marketCap":43082485607.36},{"date":"2021-12-23","current":10.363994,"twenty":20.795645,"median":35.82744,"eighty":87.174965,"marketCap":42874132957.12},{"date":"2021-12-31","current":10.327779,"twenty":20.657578,"median":35.632629,"eighty":86.517022,"marketCap":42437110052.52},{"date":"2022-01-07","current":10.522022,"twenty":20.640925,"median":35.562823,"eighty":86.434171,"marketCap":43033429977.32},{"date":"2022-01-14","current":11.009273,"twenty":20.536864,"median":35.556871,"eighty":86.322076,"marketCap":45750368973.66},{"date":"2022-01-21","current":10.940136,"twenty":20.171308,"median":35.520843,"eighty":86.263593,"marketCap":45488233052.08},{"date":"2022-01-28","current":10.953305,"twenty":19.949589,"median":35.455688,"eighty":85.922437,"marketCap":44994125510.56},{"date":"2022-02-04","current":12.019761,"twenty":19.86233,"median":35.393845,"eighty":85.355005,"marketCap":45736794370.02},{"date":"2022-02-11","current":12.502153,"twenty":19.831282,"median":35.308236,"eighty":85.302091,"marketCap":47298200126.65},{"date":"2022-02-18","current":12.558981,"twenty":19.671006,"median":35.308236,"eighty":85.302091,"marketCap":47834673171.52},{"date":"2022-02-25","current":12.196703,"twenty":19.550551,"median":35.308236,"eighty":85.302091,"marketCap":46263555485.74},{"date":"2022-03-04","current":12.289048,"twenty":19.380891,"median":35.308236,"eighty":85.302091,"marketCap":46976698663.99},{"date":"2022-03-11","current":12.043978,"twenty":19.117196,"median":35.308236,"eighty":85.302091,"marketCap":45095629553.81},{"date":"2022-03-18","current":12.707196,"twenty":18.980245,"median":35.308236,"eighty":85.302091,"marketCap":46769031069.82},{"date":"2022-03-25","current":12.770838,"twenty":18.858799,"median":35.308236,"eighty":85.302091,"marketCap":45895036970.15},{"date":"2022-04-01","current":12.530413,"twenty":18.69121,"median":35.308236,"eighty":85.302091,"marketCap":44742437445.66},{"date":"2022-04-08","current":13.064299,"twenty":18.623126,"median":35.308236,"eighty":85.302091,"marketCap":46073289723.14},{"date":"2022-04-14","current":13.294114,"twenty":18.443795,"median":35.308236,"eighty":85.302091,"marketCap":46294767383.12},{"date":"2022-04-22","current":13.21633,"twenty":18.221438,"median":35.308236,"eighty":85.302091,"marketCap":45025239824.55},{"date":"2022-04-29","current":13.325935,"twenty":17.979017,"median":35.308236,"eighty":85.302091,"marketCap":45022632781.95},{"date":"2022-05-06","current":13.53454,"twenty":17.700642,"median":35.308236,"eighty":85.302091,"marketCap":45566277364},{"date":"2022-05-13","current":24.629857,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":43848144051.53},{"date":"2022-05-20","current":25.018997,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":45016426783.75},{"date":"2022-05-27","current":25.119636,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":45470626890.48},{"date":"2022-06-03","current":24.280973,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":42728413394.89},{"date":"2022-06-10","current":24.368194,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":41777808638.38},{"date":"2022-06-17","current":23.83145,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":40560767412.66},{"date":"2022-06-24","current":24.871564,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":42352646298.73},{"date":"2022-07-01","current":25.220478,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":42911856821.29},{"date":"2022-07-08","current":26.059148,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":44046297256.04},{"date":"2022-07-15","current":26.763631,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":44459950529.79},{"date":"2022-07-22","current":26.817305,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":45321441244.41},{"date":"2022-07-29","current":30.743571,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":45477961048.28},{"date":"2022-08-05","current":29.247514,"twenty":15.868566,"median":35.251678,"eighty":85.31532,"marketCap":42639852719.36},{"date":"2022-08-12","current":29.748811,"twenty":15.868566,"median":35.071486,"eighty":85.31532,"marketCap":43951767417.68},{"date":"2022-08-19","current":29.8898,"twenty":15.868566,"median":34.741035,"eighty":85.31532,"marketCap":43038704613},{"date":"2022-08-26","current":29.874135,"twenty":15.868566,"median":33.797644,"eighty":85.31532,"marketCap":42969756201.7},{"date":"2022-09-02","current":30.022957,"twenty":15.868566,"median":32.525364,"eighty":85.31532,"marketCap":42304023842.38},{"date":"2022-09-09","current":30.65741,"twenty":15.868566,"median":32.307982,"eighty":85.31532,"marketCap":42457872052.31},{"date":"2022-09-16","current":30.406762,"twenty":15.868566,"median":32.13589,"eighty":85.31532,"marketCap":41975860478.2},{"date":"2022-09-23","current":29.784868,"twenty":15.868566,"median":32.082779,"eighty":85.31532,"marketCap":41053322910.74},{"date":"2022-09-30","current":29.611929,"twenty":15.868566,"median":31.991351,"eighty":85.31532,"marketCap":40398024705.55},{"date":"2022-10-07","current":29.784868,"twenty":15.868566,"median":31.910861,"eighty":85.31532,"marketCap":40490115913.28},{"date":"2022-10-14","current":30.091442,"twenty":15.868566,"median":31.822929,"eighty":85.31532,"marketCap":40007811364.69},{"date":"2022-10-21","current":29.234607,"twenty":15.868566,"median":31.680102,"eighty":85.31532,"marketCap":38943108088.84},{"date":"2022-10-28","current":27.96678,"twenty":15.868566,"median":31.562866,"eighty":85.31532,"marketCap":40412932074.34},{"date":"2022-11-04","current":27.990228,"twenty":15.868566,"median":31.51076,"eighty":85.31532,"marketCap":40544936411.09},{"date":"2022-11-11","current":28.209015,"twenty":15.868566,"median":31.374814,"eighty":85.31532,"marketCap":43206259311.05},{"date":"2022-11-18","current":28.704934,"twenty":15.868566,"median":31.254645,"eighty":85.31532,"marketCap":43730486647.27},{"date":"2022-11-25","current":29.426933,"twenty":15.868566,"median":31.201154,"eighty":85.31532,"marketCap":45057111010.77},{"date":"2022-12-02","current":28.931014,"twenty":15.868566,"median":31.037761,"eighty":85.31532,"marketCap":45570767384.44},{"date":"2022-12-09","current":29.835336,"twenty":15.868566,"median":30.937343,"eighty":85.31532,"marketCap":46637499358.3},{"date":"2022-12-16","current":30.331255,"twenty":15.868566,"median":30.871973,"eighty":85.31532,"marketCap":47313819017.43},{"date":"2022-12-23","current":29.900973,"twenty":15.868566,"median":30.772934,"eighty":85.31532,"marketCap":47996239753.01},{"date":"2022-12-30","current":29.981195,"twenty":15.868566,"median":30.71556,"eighty":85.31532,"marketCap":48463304453.77},{"date":"2023-01-06","current":29.755114,"twenty":15.868566,"median":30.572454,"eighty":85.31532,"marketCap":47870974965.36},{"date":"2023-01-13","current":29.864508,"twenty":15.868566,"median":30.484406,"eighty":85.31532,"marketCap":49882681588.13},{"date":"2023-01-20","current":30.426063,"twenty":15.868566,"median":30.426063,"eighty":85.31532,"marketCap":49943652563.58},{"date":"2023-01-27","current":30.148932,"twenty":15.868566,"median":30.406762,"eighty":85.31532,"marketCap":49467797966.47},{"date":"2023-02-03","current":23.618692,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":49524315647.28},{"date":"2023-02-10","current":23.884908,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":49885153889.85},{"date":"2023-02-17","current":23.681054,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":48373362782.36},{"date":"2023-02-24","current":23.799969,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":47942402215.74},{"date":"2023-03-03","current":24.043461,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":48450666632.88},{"date":"2023-03-10","current":24.621048,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50074775527.78},{"date":"2023-03-17","current":24.802252,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":51520828536.51},{"date":"2023-03-24","current":24.139732,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50698940566.02},{"date":"2023-03-31","current":24.63238,"twenty":15.872727,"median":30.373407,"eighty":85.302091,"marketCap":50868882296.85},{"date":"2023-04-06","current":24.898523,"twenty":15.872727,"median":30.373407,"eighty":85.302091,"marketCap":51908951328.51},{"date":"2023-04-14","current":25.289243,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":52430478946.56},{"date":"2023-04-21","current":25.436471,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":52090554629.18},{"date":"2023-04-28","current":25.549723,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":52360758781.69},{"date":"2023-05-05","current":25.934781,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":53114594501.1},{"date":"2023-05-12","current":21.816188,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":51463307525.88},{"date":"2023-05-19","current":21.919152,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50148262100.11},{"date":"2023-05-26","current":22.174322,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50264110513.18},{"date":"2023-06-02","current":21.909524,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50016322403.86},{"date":"2023-06-09","current":22.247876,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50740318667.02},{"date":"2023-06-16","current":22.419504,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50575421543.16},{"date":"2023-06-23","current":22.547244,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":50034367985.85},{"date":"2023-06-30","current":22.199081,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":48652831553.96},{"date":"2023-07-07","current":21.625347,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":47542321682.04},{"date":"2023-07-14","current":21.105555,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":48436114801.39},{"date":"2023-07-21","current":21.512562,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":48597606707.51},{"date":"2023-07-28","current":22.302484,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":47655983749.28},{"date":"2023-08-04","current":22.405905,"twenty":15.864404,"median":30.349157,"eighty":85.328548,"marketCap":47472091400.73},{"date":"2023-08-11","current":22.962958,"twenty":15.864404,"median":30.308236,"eighty":85.328548,"marketCap":47925971293.26},{"date":"2023-08-18","current":22.653484,"twenty":15.864404,"median":30.308236,"eighty":85.328548,"marketCap":46744998549.67},{"date":"2023-08-25","current":22.947484,"twenty":15.864404,"median":30.308236,"eighty":85.328548,"marketCap":47472892956.93},{"date":"2023-09-01","current":23.262116,"twenty":15.864404,"median":30.265696,"eighty":85.328548,"marketCap":48142626644.03},{"date":"2023-09-08","current":23.262116,"twenty":15.864404,"median":30.265696,"eighty":85.328548,"marketCap":47619131084.19},{"date":"2023-09-15","current":25.06738,"twenty":15.864404,"median":30.239629,"eighty":85.328548,"marketCap":51339735089.9},{"date":"2023-09-22","current":24.298853,"twenty":15.864404,"median":30.152523,"eighty":85.328548,"marketCap":49671905160.78},{"date":"2023-09-29","current":23.9378,"twenty":15.864404,"median":30.101284,"eighty":85.328548,"marketCap":48306094881.06},{"date":"2023-10-06","current":23.12801,"twenty":15.864404,"median":30.064639,"eighty":85.328548,"marketCap":46912236069.61},{"date":"2023-10-13","current":23.4478,"twenty":15.864404,"median":30.064639,"eighty":85.328548,"marketCap":47185225879.19},{"date":"2023-10-20","current":22.447168,"twenty":15.864404,"median":30.035164,"eighty":85.328548,"marketCap":45133632614.81},{"date":"2023-10-27","current":33.018744,"twenty":15.848805,"median":30.061417,"eighty":85.468491,"marketCap":42045438777.36},{"date":"2023-11-03","current":33.977052,"twenty":15.848805,"median":30.109117,"eighty":85.468491,"marketCap":43262280273.82},{"date":"2023-11-10","current":34.001614,"twenty":15.848805,"median":30.156114,"eighty":85.468491,"marketCap":43146195810.29},{"date":"2023-11-17","current":34.509223,"twenty":15.848805,"median":30.265619,"eighty":85.468491,"marketCap":43924997173.45},{"date":"2023-11-24","current":34.411351,"twenty":15.848805,"median":30.338548,"eighty":85.468491,"marketCap":44071202551.42},{"date":"2023-12-01","current":34.149357,"twenty":15.848805,"median":30.406762,"eighty":85.468491,"marketCap":44271809028.5},{"date":"2023-12-08","current":33.224188,"twenty":15.856081,"median":30.46982,"eighty":85.355005,"marketCap":44164475676.92},{"date":"2023-12-15","current":32.708387,"twenty":15.856081,"median":30.676992,"eighty":85.355005,"marketCap":44261463171.18},{"date":"2023-12-22","current":32.732997,"twenty":15.856081,"median":31.207345,"eighty":85.355005,"marketCap":44132705649.12},{"date":"2023-12-29","current":33.191488,"twenty":15.848805,"median":31.270394,"eighty":85.468491,"marketCap":45078827041.22},{"date":"2024-01-05","current":35.107326,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46553386498.52},{"date":"2024-01-12","current":35.467569,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46529118760.4},{"date":"2024-01-19","current":35.574004,"twenty":15.834252,"median":31.485125,"eighty":85.695464,"marketCap":46054562134.98},{"date":"2024-01-26","current":35.287452,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":45813893702.51},{"date":"2024-02-02","current":37.669312,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":45919514328.61},{"date":"2024-02-09","current":37.493246,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":44733412617.38},{"date":"2024-02-16","current":38.84015,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46075141205.13},{"date":"2024-02-23","current":39.033823,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46211688108.13},{"date":"2024-03-01","current":38.637675,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":45954550562.52},{"date":"2024-03-08","current":38.311953,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":46140815426.08},{"date":"2024-03-15","current":37.871788,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":45561442683.96},{"date":"2024-03-22","current":38.796134,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":45585981704.56},{"date":"2024-03-28","current":37.000261,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":43584427473.65},{"date":"2024-04-05","current":36.269795,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":42616375994.67},{"date":"2024-04-12","current":36.498683,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":42430179712.64},{"date":"2024-04-19","current":35.820825,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":41294416133.79},{"date":"2024-04-26","current":35.997119,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41249770241.05},{"date":"2024-05-03","current":36.314041,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":42076379836.26},{"date":"2024-05-10","current":36.349255,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41627594417.07},{"date":"2024-05-17","current":44.976968,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41733682877.63},{"date":"2024-05-24","current":45.020529,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41285104836.56},{"date":"2024-05-31","current":45.445251,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41644103120.04},{"date":"2024-06-07","current":46.087779,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":42404430023},{"date":"2024-06-14","current":45.107651,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41300590483.72},{"date":"2024-06-21","current":43.866156,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":39610552206.76},{"date":"2024-06-28","current":45.436656,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":40691773038.88},{"date":"2024-07-05","current":46.209907,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":41429859502.63},{"date":"2024-07-12","current":47.281654,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":43144411716.7},{"date":"2024-07-19","current":46.533596,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":42599959119.02},{"date":"2024-07-26","current":46.698609,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":43774096625.98},{"date":"2024-08-02","current":44.272889,"twenty":15.841528,"median":31.485125,"eighty":84.95809,"marketCap":45300242074.37},{"date":"2024-08-09","current":43.014896,"twenty":15.841528,"median":31.485125,"eighty":84.034079,"marketCap":44025677518.59},{"date":"2024-08-16","current":45.710595,"twenty":15.841528,"median":31.485125,"eighty":83.611233,"marketCap":46246726032.37},{"date":"2024-08-23","current":46.418876,"twenty":15.841528,"median":31.485125,"eighty":83.285679,"marketCap":48080793858.92},{"date":"2024-08-30","current":45.805737,"twenty":15.841528,"median":31.485125,"eighty":82.840382,"marketCap":47110126928.06},{"date":"2024-09-06","current":45.150312,"twenty":15.841528,"median":31.485125,"eighty":82.567216,"marketCap":47633333133.33},{"date":"2024-09-13","current":43.733749,"twenty":15.841528,"median":31.485125,"eighty":82.35018,"marketCap":46692187320.02},{"date":"2024-09-20","current":45.192598,"twenty":15.841528,"median":31.485125,"eighty":81.917164,"marketCap":46914983400.73},{"date":"2024-09-27","current":44.008604,"twenty":15.841528,"median":31.485125,"eighty":81.717782,"marketCap":46173769906.47},{"date":"2024-10-04","current":44.8226,"twenty":15.841528,"median":31.485125,"eighty":81.193902,"marketCap":45207064894.75},{"date":"2024-10-11","current":45.034027,"twenty":15.841528,"median":31.485125,"eighty":80.903118,"marketCap":45273197191.14},{"date":"2024-10-18","current":45.203169,"twenty":15.841528,"median":31.485125,"eighty":80.121066,"marketCap":45314702691.87},{"date":"2024-10-25","current":43.395465,"twenty":15.841528,"median":31.485125,"eighty":79.259288,"marketCap":42802477236.79},{"date":"2024-11-01","current":23.34074,"twenty":15.841528,"median":31.394177,"eighty":76.252009,"marketCap":44255337707.7},{"date":"2024-11-08","current":23.061963,"twenty":15.841528,"median":31.223737,"eighty":52.659045,"marketCap":43818726338.15},{"date":"2024-11-15","current":23.302476,"twenty":15.841528,"median":30.720073,"eighty":52.113395,"marketCap":43649113935.95},{"date":"2024-11-22","current":22.482544,"twenty":15.841528,"median":30.492581,"eighty":51.914978,"marketCap":42094765685.01},{"date":"2024-11-29","current":22.318557,"twenty":15.841528,"median":30.428162,"eighty":51.719171,"marketCap":43004121919.03},{"date":"2024-12-06","current":22.537206,"twenty":15.841528,"median":30.363743,"eighty":51.54686,"marketCap":43593417925.5},{"date":"2024-12-13","current":22.602801,"twenty":15.841528,"median":30.265696,"eighty":51.06387,"marketCap":42654808427.14},{"date":"2024-12-20","current":22.438814,"twenty":15.841528,"median":30.156169,"eighty":50.729692,"marketCap":41620825476.96},{"date":"2024-12-27","current":22.89251,"twenty":15.841528,"median":30.11976,"eighty":50.270198,"marketCap":42157933916.75},{"date":"2025-01-03","current":22.854246,"twenty":15.841528,"median":30.084614,"eighty":49.695831,"marketCap":42120101324.52},{"date":"2025-01-10","current":22.526274,"twenty":15.834252,"median":30.039538,"eighty":48.706353,"marketCap":41387819255.78},{"date":"2025-01-17","current":22.072578,"twenty":15.834252,"median":29.98139,"eighty":47.742982,"marketCap":40954868347.09},{"date":"2025-01-24","current":22.056179,"twenty":15.834252,"median":29.928964,"eighty":47.376261,"marketCap":41086375616.12},{"date":"2025-01-31","current":32.066996,"twenty":15.834252,"median":29.8898,"eighty":47.184847,"marketCap":43068627249.87},{"date":"2025-02-07","current":31.518451,"twenty":15.834252,"median":29.8898,"eighty":46.698609,"marketCap":43370831342.3},{"date":"2025-02-14","current":31.625402,"twenty":15.834252,"median":29.8898,"eighty":46.623803,"marketCap":43271885610.15},{"date":"2025-02-21","current":32.135858,"twenty":15.834252,"median":29.8898,"eighty":46.463276,"marketCap":44737299221.36},{"date":"2025-02-28","current":33.019632,"twenty":15.834252,"median":29.8898,"eighty":46.1861,"marketCap":45710719655.87},{"date":"2025-03-07","current":33.965435,"twenty":15.826975,"median":29.881968,"eighty":45.994515,"marketCap":47968574450.17},{"date":"2025-03-14","current":32.579894,"twenty":15.826975,"median":29.881968,"eighty":45.856479,"marketCap":45709305301.84},{"date":"2025-03-21","current":33.462021,"twenty":15.826975,"median":29.881968,"eighty":45.756962,"marketCap":46697220950.86},{"date":"2025-03-28","current":32.837181,"twenty":15.826975,"median":29.881968,"eighty":45.646342,"marketCap":45537525126.69},{"date":"2025-04-04","current":32.910692,"twenty":15.826975,"median":29.881968,"eighty":45.486482,"marketCap":46959977925.4},{"date":"2025-04-11","current":28.911716,"twenty":15.834252,"median":29.864508,"eighty":45.423604,"marketCap":41903036554.51},{"date":"2025-04-17","current":30.516053,"twenty":15.834252,"median":29.864508,"eighty":45.37687,"marketCap":44665727413.14},{"date":"2025-04-25","current":31.299454,"twenty":15.826975,"median":29.853656,"eighty":45.205165,"marketCap":45236702475.67},{"date":"2025-05-02","current":32.353752,"twenty":15.826975,"median":29.853656,"eighty":45.143969,"marketCap":46627023849.03},{"date":"2025-05-09","current":62.186826,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":46246122430},{"date":"2025-05-16","current":59.013194,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":43629573670.78},{"date":"2025-05-23","current":60.272181,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":45243750600.82},{"date":"2025-05-30","current":62.428377,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":46713186360.41},{"date":"2025-06-06","current":62.153426,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":46690667816.43},{"date":"2025-06-13","current":62.934861,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":47259274399.65},{"date":"2025-06-20","current":62.052124,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":45950911927.98},{"date":"2025-06-27","current":63.18087,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47191840400.65},{"date":"2025-07-03","current":64.005724,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47693415916.83},{"date":"2025-07-11","current":64.055104,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47209686047.66},{"date":"2025-07-14","current":63.806374,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46678287018.21}],"updateTime":1752596414125}}}